Kaitlyn Arsenault
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kaitlyn Arsenault
Kaitlyn Arsenault is recorded as CFO at Skye Bioscience, Inc. (SKYE). The proxy statement of Skye Bioscience, Inc. reports total compensation of $888,589 for Kaitlyn Arsenault in fiscal 2025, including a base salary of $450,000. Disclosed compensation is on record for 4 fiscal years. Kaitlyn Arsenault has spoken on 4 earnings calls across 1 company, most recently for Skye Bioscience, Inc. on November 10, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Skye Bioscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Lisa Anson CEO
- Punit Dhillon CEO, Chief Accounting Officer, Board Member
- Paul Grayson Chairman, Board Member
- Elena Traistaru CFO
- Peter Collum CFO
- Tu Diep COO
- Dr. Cliff Jones CTO
- Richard Janney Chief Accounting Officer
- Andrew J. Schwab Board Member
- Andrew Schwab Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Skye Bioscience, Inc. (SKYE) | Former Chief Financial Officer | $450,000 | $888,589 |
| 2024 | Skye Bioscience, Inc. (SKYE) | Former Chief Financial Officer | $365,000 | $2,266,825 |
| 2023 | Skye Bioscience, Inc. (SKYE) | Chief Financial Officer | $340,000 | $1,270,290 |
| 2022 | Skye Bioscience, Inc. (SKYE) | Chief Financial Officer | $325,856 | $469,087 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.